Elutia Inc. (ELUT) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Elutia Inc. (ELUT) closed at USD 0.74 on 2026-10-14, a change of -18 % over the past year, with a market capitalization of USD 34.94M.

Elutia Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Elutia Inc. key figures

Previous close

USD 0.74 (2026-10-14)

1-year change

-18 %

Market cap

USD 34.94M

Enterprise value

USD 19.42M

P/E ratio (trailing)

-1.23

P/E ratio (forward)

-0.72

EPS (trailing)

-0.64

EPS (forward)

-1.10

PEG ratio

n/a

Price to book

2.22

Revenue growth

-11.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.31

Employees

25

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Elutia Inc.

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Elutia Inc. and compare it with other stocks.